ABVC BioPharma, Inc.
ABVC • NASDAQ
ABVC BioPharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Uttam Yashwant Patil, with a market cap of $38.9M.
CEOUttam Yashwant Patil
Market Cap$38.9M
Biotechnology
Healthcare
Employees19.0
Websiteabvcpharma.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for ABVC BioPharma, Inc.
Date
Wednesday, April 29, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 11 earnings reports for ABVC BioPharma, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 2025 | Q3 2025 | -$0.05 | — | $796.0K | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.13 | — | - | — | 10-Q |
| Apr 30, 2025 | Q1 2025 | -$0.06 | — | - | — | 10-Q |
| Apr 15, 2025 | Q4 2024 | $0.04 | — | $2.0K | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.02 | — | $389.3K | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.09 | — | $117.1K | — | 10-Q |
| May 17, 2024 | Q1 2024 | -$0.40 | — | $1.2K | — | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$0.35 | — | $2.2K | — | 10-K/A |
| Nov 15, 2023 | Q3 2023 | -$0.82 | — | $15.9K | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.68Est: -$0.60 | -13.3% | $6.1KEst: $300.0K | -98.0% | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.60Est: -$0.50 | -20.0% | $128.3KEst: $128.0K | +0.2% | — |